| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crispr Therapeutics AG (CRSP) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 54 sells. CRSP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $13.89M | - | |
| Dir | 22.0K | $1.20M | - | |
| CFO | 19.5K | $1.06M | - | |
| Other | 19.4K | $1.05M | -3,786 | |
| Other | 17.0K | $924.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 8, 2018 | Bolzon Bradley J Phd75 | Director | Sell | 128,950 | $50.39 | $6,497,892.30 | -4.4% | |
| Apr 30, 2018 | Woiwode Thomas | Director | Sell | 30,566 | $50.29 | $1,537,137.92 | -2.0% | |
| Apr 30, 2018 | Bolzon Bradley J Phd75 | Director | Sell | 30,566 | $50.29 | $1,537,137.92 | -2.0% | |
| Apr 27, 2018 | Bolzon Bradley J Phd75 | Director | Sell | 222,258 | $50.11 | $11,136,437.01 | -6.8% | |
| Apr 27, 2018 | Woiwode Thomas | Director | Sell | 222,258 | $50.11 | $11,136,437.01 | -6.8% | |
| Apr 24, 2018 | Woiwode Thomas | Director | Sell | 22,841 | $50.99 | $1,164,655.40 | -1.3% | |
| Apr 24, 2018 | Bolzon Bradley J Phd75 | Director | Sell | 22,841 | $50.99 | $1,164,655.40 | -1.3% | |
| Apr 24, 2018 | Versant Venture Capital V, L.P. | 10% Owner | Sell | 22,841 | $50.99 | $1,164,655.40 | -1.3% | |
| Apr 23, 2018 | Versant Venture Capital Iv, L.P. | 10% Owner | Sell | 101,994 | $50.68 | $5,168,901.34 | -5.5% | |
| Apr 23, 2018 | Woiwode Thomas | Director | Sell | 101,994 | $50.68 | $5,168,901.34 | -5.5% |